![thumbnail image](https://user-assets.sxlcdn.com/images/676507/FiTA8WK-FQRyXrQDyd-HDkY3tpfI.png?imageMogr2/strip/auto-orient/thumbnail/1200x630>/format/png)
![broken image](http://user-assets.sxlcdn.com/images/676507/FvVv6zgfWFJ-Ip00qZRTFXqy0jJM.png?imageMogr2/strip/auto-orient/thumbnail/300x300>/quality/90!/format/png)
![broken image](http://user-assets.sxlcdn.com/images/676507/FvVv6zgfWFJ-Ip00qZRTFXqy0jJM.png?imageMogr2/strip/auto-orient/thumbnail/300x300>/quality/90!/format/png)
![broken image](http://assets.strikingly.com/assets/themes/fresh/power.png)
- Partners
- …
- Partners
![broken image](http://user-assets.sxlcdn.com/images/676507/FvVv6zgfWFJ-Ip00qZRTFXqy0jJM.png?imageMogr2/strip/auto-orient/thumbnail/300x300>/quality/90!/format/png)
![broken image](http://user-assets.sxlcdn.com/images/676507/FvVv6zgfWFJ-Ip00qZRTFXqy0jJM.png?imageMogr2/strip/auto-orient/thumbnail/300x300>/quality/90!/format/png)
![broken image](http://assets.strikingly.com/assets/themes/fresh/power.png)
- Partners
- …
- Partners
![broken image](http://user-assets.sxlcdn.com/images/676507/FvVv6zgfWFJ-Ip00qZRTFXqy0jJM.png?imageMogr2/strip/auto-orient/thumbnail/300x300>/quality/90!/format/png)
Immune-oncology Agonistic Antibodies
Cross-linking (xLinkTM)Synthetic Biology
Tumor-targeted Immune Activation
Lyvgen Biopharma Website 礼进生物 英文官网
Lyvgen is a biotech company focused on developing novel therapies for cancer. Lyvgen’s xLinkAb™ functional platform creates agonist antibodies (Abs) with tumor-localized immunostimulatory activities by balancing multiple functions of candidate Abs.
https://user-assets.sxlcdn.com/images/676507/FiTA8WK-FQRyXrQDyd-HDkY3tpfI.png?imageMogr2/strip/auto-orient/thumbnail/1200x630>/format/png